Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Nasopharyngeal Neoplasms × Gemcitabine × Clear all

Phase

Phase 3 8 Phase 2 7 Phase 1/2 3 Phase NA 1 Phase 4 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 3 Pancreatic Neoplasms 2 Lymphoma, T-Cell, Peripheral 2 Squamous Non-small-cell Lung Cancer 1 Oligospermia 1 Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Fibrosis 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Biliary Tract Neoplasms 1 Adenocarcinoma Pancreas 1 Adenocarcinoma 1

Interventions

toripalimab 1 Tobacco Use Cessation Devices 1 Psychiatric Rehabilitation 1 Polymerase Chain Reaction 1 Gene Expression Profiling 1 Gemcitabine 1 Early Intervention, Educational 1 Counseling 1 Cisplatin 1 Carboplatin 1 Bupropion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06457503 2026-03-02

TRANSPARENT

Coherus Oncology, Inc.

Phase 4 Recruiting

Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡